Correspondence 0001213900-23-022448 from Jin Medical International Ltd. (ZJYL)
Jin Medical International Ltd.
Date: March 23, 2023 · CIK: 0001837821 · Accession: 0001213900-23-022448
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-259767
Letter
RE: Jin Medical International Ltd. (CIK: 0001837821)
March 23, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Registration Statement No. 333-259767 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), Prime Number Capital, LLC hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time, March 27, 2023, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that we will distribute as many electronic copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution.
By: Prime Number Capital, LLC
By: /s/ Xiaoyan Jiang
Name: Xiaoyan Jiang
Title: Chairwoman
Show Raw Text
CORRESP
1
filename1.htm
March 23, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Jin Medical International Ltd. (CIK: 0001837821)
Registration Statement No. 333-259767 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and
Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”),
Prime Number Capital, LLC hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it
will become effective at 5:00 p.m. Eastern Time, March 27, 2023, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act,
please be advised that we will distribute as many electronic copies of the proposed form of preliminary prospectus as appears to be reasonable
to secure adequate distribution.
By:
Prime Number Capital, LLC
By:
/s/ Xiaoyan Jiang
Name:
Xiaoyan Jiang
Title:
Chairwoman